Evaluation of VAL-083 in GBM AGILE, a Phase 3 Registration Platform Trial for Newly Diagnosed and Recurrent Glioblastoma.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined